MEGAN LEE: Open Payments
NPI 1306205653 · NATCHITOCHES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 21 payments from 5 companies in 2025. Trend: 2023 $317 · 2024 $238 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 12 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Astellas Pharma US Inc | 3 | $49 |
| Sage Therapeutics, LLC | 1 | $32 |
| Evofem Biosciences, Inc. | 2 | $25 |
Products named: MYFEMBREE, Veozah, ZURZUVAE, Phexxi, GEMTESA, Mirena, Lynkuet, Nubeqa.
Industry payments across LA — which companies pay providers there.
